Advanced company searchLink opens in new window

SUTURA THERAPEUTICS LIMITED

Company number 12385038

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
19 Aug 2024 MR01 Registration of charge 123850380001, created on 31 July 2024
19 Apr 2024 CS01 Confirmation statement made on 8 March 2024 with updates
16 Feb 2024 AA Total exemption full accounts made up to 31 December 2023
01 Sep 2023 AA Total exemption full accounts made up to 31 December 2022
15 May 2023 TM01 Termination of appointment of Lars Christian Wilde as a director on 30 April 2023
15 May 2023 TM01 Termination of appointment of Eduardo Bravo Fernandez De Araoz as a director on 30 April 2023
28 Apr 2023 SH08 Change of share class name or designation
21 Apr 2023 SH01 Statement of capital following an allotment of shares on 14 November 2022
  • GBP 1,435.83
19 Apr 2023 CS01 Confirmation statement made on 8 March 2023 with updates
20 Jan 2023 PSC02 Notification of Apeiron Sicav Limited - Elevat3 Capital Fund One as a person with significant control on 16 September 2022
18 Jan 2023 TM01 Termination of appointment of Keith Foster as a director on 18 January 2023
16 Jan 2023 PSC07 Cessation of Keith Foster as a person with significant control on 16 September 2022
05 Dec 2022 AA Total exemption full accounts made up to 31 December 2021
05 Sep 2022 AP01 Appointment of Dr Edwin Jacob Wagena as a director on 31 August 2022
04 Jul 2022 TM01 Termination of appointment of Alexander David Jackson Smith as a director on 28 June 2022
04 Jul 2022 CH01 Director's details changed for Dr Keith Foster on 4 July 2022
08 Mar 2022 CS01 Confirmation statement made on 8 March 2022 with updates
06 Oct 2021 AP01 Appointment of Dr Volker Knappertz as a director on 29 September 2021
30 Sep 2021 AA Micro company accounts made up to 31 December 2020
28 Sep 2021 CS01 Confirmation statement made on 28 September 2021 with updates
28 Sep 2021 SH01 Statement of capital following an allotment of shares on 16 August 2021
  • GBP 1,354.46
06 Aug 2021 TM01 Termination of appointment of Mark Granville Beards as a director on 4 August 2021
04 Aug 2021 AP01 Appointment of Dr Keith Foster as a director on 15 July 2021
04 Aug 2021 AP01 Appointment of Mr Thomas Hanke as a director on 15 July 2021
17 Jun 2021 CH01 Director's details changed for Mr Mark Granville Beards on 15 June 2021